|
The Medicines Company (Nasdaq: MDCO) specializes in acute care hospital pharmaceutical products. MDCO acquires, develops and commercializes products in late stages of their development. Its first acute care hospital product, Angiomax® (bivalirudin), is a direct thrombin inhibitor used as an anticoagulant in patients undergoing coronary angioplasty. MDCO is currently developing two additional late development stage pharmaceutical products as potential acute care hospital products.
more »
|
|
|
